Yacktman Asset Management Dumps $18 Million of Ingredion (NYSE: INGR) Shares: Is the Stock a Sell?
Yacktman sold 135,400 shares of Ingredion, with a transaction value of $17,451,241 based on its quarterly average price. The trade represents approximately 0.24% of 13F AUM.
Ingredion Incorporated (INGR) Q3 2025 Earnings Call Transcript
Ingredion Incorporated ( INGR ) Q3 2025 Earnings Call November 4, 2025 9:00 AM EST Company Participants Noah Weiss - Vice President of Investor Relations James Zallie - President, CEO & Director Jim Gray - Executive VP & CFO Conference Call Participants Andrew Strelzik - BMO Capital Markets Equity Research Kristen Owen - Oppenheimer & Co. Inc., Research Division Benjamin Theurer - Barclays Bank PLC, Research Division Pooran Sharma - Stephens Inc., Research Division Joshua Spector - UBS Investment Bank, Research Division Heather Jones - Heather Jones Research LLC Presentation Operator Good day, and welcome to the Ingredion Q3 2025 Earnings Call. [Operator Instructions] At this time, that today's conference is being recorded.
Ingredion (INGR) Q3 Earnings Top Estimates
Ingredion (INGR) came out with quarterly earnings of $2.75 per share, beating the Zacks Consensus Estimate of $2.73 per share. This compares to earnings of $3.05 per share a year ago.
Analysts Estimate Ingredion (INGR) to Report a Decline in Earnings: What to Look Out for
Ingredion (INGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ingredion: Strong Guidance, Solid Balance Sheet, And A Cheaper Entry Point
Ingredion remains a Buy, with improved financials, strong cash flows, and improved shareholder returns despite recent stock weakness. INGR raised its EPS outlook, increased its dividend, and expects cost savings from its Cost2Compete program, supporting long-term growth. Macroeconomic catalysts like further rate cuts and easing political uncertainty could further benefit INGR, though regulatory risks persist.
Ingredion Incorporated (INGR) Analyst/Investor Day Transcript
Ingredion Incorporated (NYSE:INGR ) Analyst/Investor Day September 17, 2025 9:00 AM EDT Company Participants Noah Weiss - Vice President of Investor Relations James Zallie - President, CEO & Director Michael O'Riordan - SVP of Texture & Healthful Solutions, EMEA & Asia-Pacific Rob Ritchie - Executive VP of Food & Industrial Ingredients of LATAM, US/Canada and Sugar Reduction Michael Leonard - Senior VP, Chief Innovation Officer & Head of Protein Fortification Jim Gray - Executive VP & CFO Conference Call Participants Benjamin Theurer - Barclays Bank PLC, Research Division Kristen Owen - Oppenheimer & Co. Inc., Research Division Christina Cornacchia McGlone-Hahn G. Leonard Teitelbaum James Cannon - UBS Investment Bank, Research Division Pooran Sharma - Stephens Inc., Research Division Heather Jones - Heather Jones Research LLC Presentation Noah Weiss Vice President of Investor Relations Good morning, and welcome to Ingredion's 2025 Investor Day here in New York, and greetings to everyone joining us online around the world.
INGR vs. DANOY: Which Stock Is the Better Value Option?
Investors interested in Food - Miscellaneous stocks are likely familiar with Ingredion (INGR) and Danone (DANOY). But which of these two stocks presents investors with the better value opportunity right now?
Ingredion (INGR) Upgraded to Buy: Here's What You Should Know
Ingredion (INGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
INGR or DANOY: Which Is the Better Value Stock Right Now?
Investors interested in Food - Miscellaneous stocks are likely familiar with Ingredion (INGR) and Danone (DANOY). But which of these two companies is the best option for those looking for undervalued stocks?
Ingredion (INGR) Loses 7.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Ingredion (INGR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Ingredion (INGR) Loses 7.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Ingredion (INGR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Should Value Investors Buy Ingredion (INGR) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
